Navigation Links
Study highlights HIV/AIDS challenge in American prison system
Date:9/29/2009

This release is available in French.

MONTREAL, 29 September 2009 HIV/Aids is up to five times more prevalent in American prisons than in the general population. Adherence to treatment programs can be strictly monitored in prison. However, once prisoners are released, medical monitoring becomes problematic. A new study by Dr. Nitika Pant Pai an Assistant professor of Medicine and a medical scientist at the Research Institute of the MUHC suggests the majority (76%) of inmates take their antiretroviral treatment (ART) intermittently once they leave prison, representing a higher risk to the general population.

"Over a period of 9 years, we studied 512 HIV positive repeat offender inmates from the San Francisco County jail system," says Dr. Pant Pai. "Our results show that only 15% continuously took their ART between incarcerations or after their release." According to the study, published in the journal PLoS one, these figures highlight a lack of effectiveness on the part of medical monitoring services for these people outside prison.

"Taking ART intermittently is a problem because it depletes the CD4 count - the immunizing cells that fight infection and increases the probability of developing resistance to the virus," says Dr. Pant Pai. "The risk for rapid disease progression becomes higher and presents a risk for public health transmission of HIV to their partners." According to the study those on intermittent therapy were 1.5 times more likely to have higher virus load than those on continuous therapy; those who never received therapy were 3 times more likely to have a higher VL.

"The optimal solution for treating patients and controlling the HIV/Aids epidemic in the USA is to ensure continuous therapy," explains Dr. Milton Estes, medical director of Forensic AIDS Project, San Francisco. "To achieve this we must work on various aspects of the prisoner's lives, such as marginalization, psychiatric problems and drug use, both before and after their departure from prison." According to Dr. Jacqueline Tulsky, senior author of the study, "This research highlights the need to examine ART policies inside and outside correctional settings with a view to establishing effective life long management of HIV in prisoners."

"This research is the first observational study in American prisons to evaluate the impact of antiretroviral treatment (ART) over a nine year period. It demonstrates the need for effective community transition and prison release programs to optimize ART given in jails," explains Dr. Pant Pai.


'/>"/>

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-843-1560
McGill University Health Centre
Source:Eurekalert

Related medicine news :

1. Study outlines strategies to test new payment models for health care
2. Study suggests obesity alone does not cause knee osteoarthritis in mice
3. Institute for Aging Research study links high-heels to heel and ankle pain
4. Heart Patients Benefit From At-Home Care, Study Finds
5. U-M study: Life and death during the Great Depression
6. UCLA study identifies 2 chemicals that could lead to new drugs for genetic disorders
7. New study resolves the mysterious origin of Merkel cells
8. Many Kids Suffer Medication Side Effects: Study
9. Swiss study finds income affects prostate cancer patients survival
10. Study finds intervention program increases kids healthy eating, reduces screen time
11. Exercise May Prevent Prostate Cancer: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... thrilled to announce the ATA 2017 President’s Awards recipients, comprised of organizations ... superior healthcare delivery. , The ATA 2017 President’s Awards recognize individuals ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... Excellence specializes in pelvic conditions and has helped many women become pregnant upon ... a combination of office-based and simple outpatient evaluations. We can provide the ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... for sponsors and CROs to speed clinical development, has released the industry’s ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management ...
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting ... Invisalign® in Lutz, FL. With the help of this highly-effective, yet convenient system, ... potential complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market ... has covered and analysed the potential of Global Effective Microorganisms ... shares and growth factors. The report identifies and analyses the ... the global market. ... 152 Tables and Figures, 6 Major Company Profiles, spread across ...
Breaking Medicine Technology: